Q17: What revenue code goes with CPT 96372
Formulated with glutathione
SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors) : Similar to SSRIs, Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) increase serotonin availability and are also used to treat depression and anxiety, offering additional benefits for mood regulation during recovery
It tells the pituitary gland to release GH without affecting cortisol
The "minimal initial benefit" group (approximately 5-10% of users) reported limited improvements during treatment making discontinuation effects irrelevant, typically explained by inadequate product quality with degraded or low-concentration GHK-Cu, inappropriate application technique reducing absorption, unrealistic expectations exceeding what any topical can achieve, severe underlying pathology requiring medical intervention beyond cosmetic peptides, or individual non-responsiveness to copper peptide treatment for genetic or physiological reasons
Net per vial: 50 mg (filled to approximately 104% of label)